Evonik

Leading Beyond Chemistry

Company Presentation Q3 2020

Key Messages Q3 Roadshow Season

Portfolio delivering resilience in challenging environment

Strategy execution well on track

  • Acquisition of Porocel
  • Announced Baby Care carveout
  • Asset optimization in Methionine

Sustainability as key driver in innovation

  • Next generation of ready-to-usePA12 powders for 3D printing - 80% reusability
  • Biosurfactants: Evonik as key pillar in Unilever's "Clean future" initiative

Portfolio has proven resilience YTD

  • Robust performance driven by growth divisions with only -1%yoy and stable pricing
  • Many businesses virtually unaffected by the crisis

"Promise and deliver" - EBITDA outlook confirmed & FCF outlook increased

  • EBITDA outlook now narrowed:
    Range of €1.8 bn to €2.0 bn
  • FCF upgraded once more:
    FCF ~€700 m and CCR >35%

2

Table of contents

  1. Evonik at a glance
  2. Strategy
  3. Financials Q3 2020
  4. Appendix

3

LEADING BEYOND CHEMISTRY

TO IMPROVE LIFE, TODAY AND TOMORROW

4

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

Evonik Industries AG published this content on 12 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 January 2021 07:23:01 UTC